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Abstract: Novel heteroleptic iridium complexes containing the 1-substituted-4-phenyl-1H-
1,2,3-triazole (phtl) cyclometalating ligand have been synthesized. The 3+2 Huisgen 
dipolar cycloaddition method (‘click’ chemistry) was utilized to prepare a class of 
bidentate ligands (phtl) bearing different substituents on the triazole moiety. By using 
various ligands (phtl-R1 and pytl-R2) (R1=adamantane, methyl and R2=adamantane, 
methyl, β-cyclodextrin, ursodeoxycholic acid), we prepared a small library of new 
luminescent ionic iridium complexes [Ir(phtr-R1)2(pytl-R2)]Cl and report on their 
photophysical properties. The flexibility of the clicking approach allows a straightforward 
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control on the chemical-physical properties of the complexes by varying the nature of the 
substituent on the ligand. 
Keywords: click chemistry; phenyl-triazole; pyridine-triazole; iridium; luminescence 
 
1. Introduction 
The photoluminescence of organometallic complexes has attracted much interest since it can be 
utilized for a variety of applications such as oxygen sensors, biological probes and phosphorescent 
dopants in optoelectronic devices [1,2]. In particular, cyclometalating complexes of iridiumIII have 
received great attention because of the high tunability of their emission in terms of color and 
efficiency. This has been achieved by screening a large variety of cyclometalating and ancillary 
ligands, often bearing functional groups with electron withdrawing or releasing properties. While 
much has been done on the investigation of the photophysical properties of iridiumIII complexes, little 
attention has been focused on controlling other properties like solubility and polarity. The increasing 
number of applications of such compounds has made this aspect more appealing; it is indeed 
important, for example, to have photo-active materials which are water soluble in order to incorporate 
them in electrochemiluminescence (ECL) devices, or apolar with high affinity for hydrophobic 
matrices or with ‘sticky’ tails able to selectively recognize guests on modified surfaces [3]. The best 
approach to obtain complexes with designed physico-chemical properties is through the 
functionalization of ligands with selected substituents. Unfortunately, most of the ligands are difficult 
to prepare or their synthesis requires a large number of steps [4–7]. Their functionalization is not 
always trivial as it usually implies aromatic substitution reactions (on the phenyl or pyridyl moities) 
and coupling reactions. This all leads to an increase in the cost of the material itself and to a limited 
applicability. We now report on an exploration of the application of the Huisgen Cu-catalyzed [3+2] 
cycloaddition as an efficient and flexible means to prepare a class of bidentate cyclometalated ligands, 
1-substituted-4-phenyl-1H-1,2,3-triazole (phtl) (1 and 2, Scheme 1) [8]; we have also investigated 
whether stable luminescent heteroleptic iridium complexes could be formed (Scheme 1), and what 
properties emerge from the use of such a 1,2,3-triazole-containing chelator. The substituents we used 
to functionalize pytl [2-(1-substituted-1H-1,2,3-triazol-4-yl)pyridine] and phtl [i.e., βCD, adamantanes, 
ursodeoxycholic acid (UDC) derivative and methyl] are examples of moieties provided with different 
chemico-physical properties. Decoration of a metal complex with these residues does not influence the 
electronic properties of the molecule and thus it does not affect directly its correlated luminescent 
properties. However, it can add other properties to the metal complex providing us with multi-
functional materials. We prepared a small library of phosphorescent complexes bearing either host 
(βCD) or guest molecules (adamantane, UDC-derivative). Cyclodextrins are well-known cyclic 
oligosaccharides that can form inclusion complexes in aqueous solution with a variety of hydrophobic 
substrates, such as adamantane derivatives, and have been widely applied as supramolecular building 
blocks in various areas [9–14], including photoactivated electron transfer processes [6,15–18]. With 
βCD attached to [Ir(1)2(pytl-βCD)]Cl the phosphorescent dye can be immobilized on guest-appended 
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polymeric membranes, which are used as responsive materials for oxygen sensors. βCD can also act as 
second sphere ligand, enhancing the photophysical properties of [Ir(1)2(pytl-βCD)]Cl [19]. The 
presence of adamantanes in [Ir(2)2(pytl-ada)]Cl and [Ir(1)(2)(pytl-ada)]Cl allows the supramolecular 
decoration with iridium complexes of the surface of vesicles and nanoparticles covered with 
cyclodextrins [20]. Particularly interesting is the complex [Ir(1)2(pytl-DC)]Cl where a UDC derivative 
instead of adamantane was used as a host. Native UDC is a amphiphilic molecule which has high 
affinity for βCD [21] as well as for bilayer membranes [22–25]. As we show here, UDC can be easily 
functionalized through the azido group (Scheme 3). Its affinity for membranes, combined with the 
sensitivity of polyamine iridiumIII complexes to the polarity of their environment, provides us with an 
interesting luminescent polarity probe for the study of the dynamics of natural and artificial 
membranes [4,5,26]. Besides the supramolecular aspects, the nature of the substituents on the complex 
[Ir(phtl-R1)2(pytl-R2)]Cl strongly affects other properties like solubility. This can be tuned by changing 
the hydrophilicity of the ligands: the simplest complex of the series, the fully methylated [Ir(1)2(pytl-
Me)]Cl, displays a poor solubility in water which is dramatically increased in [Ir(1)2(pytl-βCD)]Cl by 
the introduction of one per-methylated βCD.  
Scheme 1. Structures of 1 and 2 and their heteroleptic iridium complexes. 
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2. Results and Discussion 
2.1. Synthesis of phtl and pytl ligands and their iridium complexes 
The Huisgen cycloaddition, also known as ‘click reaction’ [27], involves the formation of 1,2,3-
triazole rings by coupling terminal alkynes and azides. It can be used to prepare the phtl ligand in one 
step, by reacting ethynylbenzene with an azide-containing molecule. The known high efficiency of this 
reaction, combined with its tolerance to other functional groups [27], allows the introduction of the 
phtl (and pytl) ligand on many different substrates (i.e. methyl, adamantane, bile acid) [19,28,29], 
requiring only the presence of at least one azido group on the molecule of interest. Therefore, this 
approach makes a large library of cyclometalating ligands readily accessible. The ligands 1 and 2 were 
prepared by reacting azidomethane and 1-azidoadamantane with ethynylbenzene for two hours in 
deoxygenated THF, in the presence of CuBr and pentamethyldiethylenetriamine (PMDTA). The 
products were isolated in 43% and 76% yield, respectively. The click reaction was used to prepare also 
the ancillary ligands pytl-R, by reacting 2-ethynylpyridine with the corresponding azido-appended 
derivatives in identical conditions (Scheme 2) as reported previously [19]. In addition to full 
characterization by NMR and mass spectrometry, the crystal structures of the ligands 1 and 2 were 
obtained by single crystal X-ray diffraction (Table S1, Figure S1 and S2).  
Scheme 2. Synthesis and structures of the ligands phtl-R and pytl-R. 
 
 
The preparation of the ligand 3β-(4'-(pyridin-6'-yl)-1'H-1',2',3'-triazol-1'-yl)-7β-hydroxy-5β-cholan-
24-oic acid (pytl-DC) required the synthesis of 3β-azido-7β-hydroxy-5β-cholan-24-oic acid methyl 
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ester 7 (Scheme 3). This was achieved by adapting the procedure described in the literature for the 
azidation of cholic acid [30]. The carboxylic group was initially protected as methyl ester to avoid 
undesired reactions and the hydroxyl group converted into a better leaving group by tosylation. The 
latter step produces a mixture of tosylated derivatives that was further used without purification. The 
substitution of the tosylate by sodium azide accomplished a mixture of 6 and 7 separated by 
chromatography. Both compounds are very interesting for bio- and supramolecular applications. Due 
to the ability of the azido group to undergo different chemical modifications (click reaction, reduction 
to amino group), they can be appended to a wide range of substrates.  
Scheme 3. Synthesis of the cholic acid derivatives 6-8. 
 
 
In addition to full characterization by NMR spectroscopy and mass spectrometry, the crystal 
structures of the carboxylic acids derivatives pytl-DC, 6a and 7a (Figure 1 and Table S2) were 
determined by single crystal X-Ray diffraction. It should be noted that the nucleophilic substitution of 
the tosyl group occurred with a bimolecular (SN2) mechanism resulting in the inverted stereochemistry 
of the carbon atom. This was proved by the crystal structures of 6a and 7a which clearly show that the 
azide is in an axial position (Figure 1). This aspect is particularly important in the case of 7a because a 
derivative with a molecular rod-like shape results when the pytl moiety is attached (Figure 1). We note 
that, due to the inversion at the carbons 3 and 7 in ursodeoxycholic acid, 6a and 7a have in fact the 
configurations of chenodeoxycholic and isoursodeoxycholic acid, respectively, according to accepted 
deoxycholic acid nomenclature [31]. 
It is interesting to notice that the clicking approach allows the functionalization of phtl and pytl 
with substituents which display very different molecular complexity. We explored here the range from 
a simple methyl group to deoxycholic acid, which has a four-ring steroidal structure with two hydroxyl 
groups and one carboxylic acid functionality. The efficiency and high flexibility of such an approach 
provides a powerful tool for the preparation of large libraries of bidentate ligands. 
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Figure 1. Crystal structures of pytl-DC, 6a and 7a. Gray, carbon; blue, nitrogen; red, 
oxygen. The thermal ellipsoids for the image represent 25% probability limit. Hydrogen 
atoms are omitted for clarity. 
 
 
The synthesis of an iridiumIII complex is usually accomplished through a two-step process: the 
Nonoyama reaction that yields a chloride-bridged dinuclear iridium species [32] followed by the 
substitution of the chlorides with an ancillary ligand (Scheme 4). The iridiumIII dimers [(1)2Ir-μ-Cl]2 
and [(2)2Ir-μ-Cl]2 were prepared by reacting 1 or 2 with IrCl3, in a mixture water/2-methoxyethanol 
1/3 (v/v) at 97 ºC. The compound [(1)(2)Ir-μ-Cl]2 was prepared by using an equimolar mixture of 1 
and 2, which afforded a mixture of dinuclear species difficult to separate and further reacted without 
purification. All the complexes were obtained by reacting the corresponding iridium dimer with a 
bidentate pytl ligand (Scheme 4) under mild conditions, in a chloroform/methanol 3:1 (v/v) mixture at 
45 °C. After 3 hours the formation on TLC of only one new spot was observed, characterized (in 
contrast to the starting compound) by a bright luminescence under UV-Vis lamp at 366 nm. All the 
complexes, except for [Ir(1)(2)(pytl-ada)]Cl, were purified by silica column chromatography or 
preparative layer chromatography (PLC). In the case of [Ir(1)(2)(pytl-ada)]Cl, the non-selective 
synthesis resulted in a mixture of different iridium species which could not be isolated by traditional 
silica chromatography. We overcame this problem by using an HPLC apparatus equipped with a semi-
preparative reversed-phase column. The characterization was done by means of NMR spectroscopy 
and high-resolution mass spectrometry. Compound [Ir(1)(2)(pytl-ada)]Cl is an example of 
cyclometalated complex where three different ligands are present: 1, 2 and pytl-ada. It was synthesized 
to investigate the possibility to prepare complexes with a higher degree of functionalization. To our 
knowledge complexes with these structural characteristics have not been reported to date. 
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Scheme 4. Synthesis of the iridiumIII complexes. 
 
 
Cyclometalated iridium complexes have an octahedral geometry. The relative spatial orientation of 
the substituents around the metal center depends on whether they are attached to the cyclometalating 
or the ancillary ligands. In fact, it is known that in the chloride-bridged dinuclear iridium complex 
prepared with the Nonoyama reaction the cyclometalating ligands are always oriented in a trans 
position with respect to each other. In particular, the two nitrogens of the phtl ligands are aligned along 
a common axis together with the central iridium atom [33]. The pytl, which is inserted in the second 
synthetic step, is located on the plane perpendicular to that axis. By taking advantage of the well-
established orientation of the ligands around the complex, considering that both phtl and pytl can be 
prepared starting from the same azide-appended molecule, we were able with our approach to control 
the location of the substituents in the iridium complex simply by clicking them to either  
2-ethynylpyridine or ethynylbenzene. 
2.2. Photophysical characterization 
All the iridium complexes are soluble in acetonitrile and these solutions were used to measure the 
absorption and emission spectra. The UV-Vis spectra of all the complexes are very similar 
(Supplementary Data); we show here only the spectrum of the iridium complex [Ir(1)(2)(pytl-ada)]Cl 
(Figure 2). The intense absorption bands present in the UV region (190–240 nm) are assigned to  
1(π-π*) transition of both phtl and pytl ligands (Figure 2). The shoulders appearing in the range 
between 290 and 350 nm are likely to be due to weaker charge transfer (CT) transitions, being of both 
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spin-allowed 1MLCT and forbidden 3MLCT nature. All complexes are luminescent in solution at room 
temperature and display very similar, broad, featureless emission spectra between 410 and 650 nm 
(emission of [Ir(1)(2)(pytl-ada)]Cl, Figure 2) with a maximum for the emission at 510 nm.  
Figure 2. UV-Vis absorption spectrum (solid) and room temperature emission spectrum 
(dotted) in acetonitrile of [Ir(1)(2)(pytl-ada)]Cl (λexc= 335 nm). 77 K emission spectrum 
(dashed) in glassy butyronitrile matrix of [Ir(1)(2)(pytl-ada)]Cl (λexc= 335 nm). 
 
According to previously published work concerning analogous cyclometalated iridiumIII complexes 
[34] such a broad emission is characteristic for a metal-to-ligand-charge-transfer excited state in 
which, formally speaking, an electron is transferred from the metal center to the ligand with the lowest 
reduction potential. If this transfer is understood as a HOMO-LUMO transition, the HOMO would be 
localized on the metal core and the LUMO orbital on the ligand. This is also consistent with the 
emission quantum efficiencies from all the complexes measured in air-equilibrated solutions which 
range from 0.021 to 0.052 (Table 1); in de-aerated conditions the compounds [Ir(1)2(pytl-Me)]Cl, 
[Ir(2)2(pytl-ada)]Cl and [Ir(1)(2)(pytl-ada)]Cl exibit a 2-3 fold increase of the emission quantum 
yields; however, for [Ir(1)2(pytl-DC)]Cl and [Ir(1)2(pytl-βCD)]Cl the increase is very large and reaches 
5-fold. For [Ir(1)2(pytl-βCD)]Cl the quantum yields are remarkably high and comparable with the 
value measured for [Ir(ppy)2(pytl-ada)]Cl where the cyclometalating ligands were ppy [19]. This 
behaviour could be explained by the tendency of molecules like β-cyclodextrin and especially 
ursodeoxycholic acid to interact (aggregate or formation of inclusion complexes) even in very dilute 
solutions; this interaction could increase the emission efficiencies by reducing the non-radiative decay 
promoted by vibrational modes. Organization of organometallic complexes in solution through micelle 
or vesicle formation, inclusion in a cyclodextrin cavity or by other means has have been shown to 
influence greatly the properties of these complexes [35]. These changes in the emissive properties of 
the compounds studied are always assigned to changes in the surrounding. For example vesicle 
formation with metallosurfactants leads to the observation of fast components in the excited state 
decay of the individual metal complexes [36]. All these complexes undergo large hypsochromic shifts 
upon cooling to 77 K (spectrum of [Ir(1)(2)(pytl-ada)]Cl, Figure 2). In a butyronitrile solid matrix the 
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maxima for the emission are blue-shifted and appear at 435 nm. Such a behavior is expected for 
compounds emitting from a charge transfer excited state and it is due to the impossibility for the 
solvent molecules to rearrange around the excited state. The consequent lack of stabilization of the 
excited state leads to a more energetic (blue-shifted) emission. The emission spectra show a series of 
vibronic transitions (emission of [Ir(1)(2)(pytl-ada)]Cl, Figure 2) which are not resolved at room 
temperature and which imply that a considerable ligand-centered (LC) character develops in these 
species at low temperature [37]. 
Table 1. Luminescence lifetimes and quantum yields of emission of the complexes. For 
quantum yield measurements λexc= 335 nm. For lifetime measurements λexc= 324 nm. The 
solutions were measured in air equilibrated acetonitrile (air) and argon saturated (Ar) for 
degassing by bubbling argon for 20-30 minutes through the solution.  
Complex Φ(air) Φ(Ar) τ (ns, air) τ (ns, Ar) 
[Ir(1)2(pytl-Me)]Cl 0.037 0.097 24.8 27.1 
[Ir(2)2(pytl-ada)]Cl 0.021 0.048 17.4 18.0 
[Ir(1)(2)(pytl-ada)]Cl 0.024 0.071 11.8 (60%)23.6 (40%) 19.7 
[Ir(1)2(pytl-DC)]Cl 0.039 0.203 24 
28.3 (84%) 
2.22 (16%) 
[Ir(1)2(pytl-βCD)]Cl 0.052 0.254 26.4 34.1 
3. Conclusions 
In conclusion, we report the preparation and the photophysical properties of new highly 
luminescent heteroleptic iridiumIII complexes. Click chemistry was used as an efficient tool to 
introduce on the phtl and pytl ligands functional groups provided with various level of complexity. 
The flexibility of such approach provides access to a large library of clicked ligands and therefore to 
multi-functional iridiumIII complexes with tunable chemico-physical properties. In particular the 
complex [Ir(1)2(pytl-DC)]Cl is a promising luminescent polarity probe for the study of membrane 
dynamics; [Ir(1)2(pytl-βCD)]Cl and [Ir(2)2(pytl-ada)]Cl are interesting building blocks for 
supramolecular systems. Here we also report the first synthesis of the 3β-azido-7β-hydroxy-5β-cholan-
24-oic acid (7a) and the isomer 3α-hydroxy-7α-azido-5β-cholan-24-oic (6a), both interesting 
intermediates for both bio- and supramolecular systems. 
4. Experimental 
4.1. General 
THF was purified by distillation under nitrogen from sodium/benzophenone and dry DMF was 
purchased from Fluka. All other chemicals were purchased from Aldrich, Fluka or Acros and used as 
received. Analytical thin layer chromatography (TLC) was performed on Merck precoated silica gel 60 
F-254 plates (layer thickness 0.25 mm) and the compounds visualized by ultraviolet (UV) irradiation 
at λ = 254 nm and/or λ = 366 nm and by staining with phosphomolybdic acid reagent or KMnO4. 
Preparative layer chromatography (PLC) was performed on Merck precoated silica gel 60 F-254 plates 
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(layer thickness 1 mm, concentrating zone 20 × 4 cm) and the compounds visualized by ultraviolet 
(UV) irradiation at λ = 254 nm and/or λ = 366 nm. Purifications by silica gel chromatography were 
performed using Acros (0.035 – 0.070 mm, pore diameter ca. 6 nm) silica gel. All click reactions were 
performed in oxygen-free atmosphere of N2 using Schlenk conditions and solvents dried and distilled 
according to standard laboratory procedures. 
Nuclear magnetic resonance (NMR): 1H-NMR spectra were recorded, at 25 °C, on a Varian Inova 400 
or a Bruker DMX-300 machines operating at 400 and 300 MHz, respectively. 13C-NMR spectra were 
recorded on a Bruker DMX-300 machine operating at 75 MHz. 1H-NMR chemical shifts (δ) are 
reported in parts per million (ppm) relative to a residual proton peak of the solvent, δ = 3.31 for 
CD3OD, δ = 7.26 for CDCl3 and δ = 2.50 for DMSO. Multiplicities are reported as: s (singlet), d 
(doublet), t (triplet), q (quartet), dd (doublet of doublets), ddd (doublet of doublet of doublets) or m 
(multiplet). Broad peaks are indicated by b. Coupling constants are reported as a J value in Hertz (Hz). 
The number of protons (n) for a given resonance is indicated as nH, and is based on spectral 
integration values. 13C-NMR chemical shifts (δ) are reported in ppm relative to a carbon peak of the 
solvent, δ = 49.0 for CD3OD, δ = 77 for CDCl3 and δ = 40 for DMSO. The signals of the protons on 
hydroxyl and carboxylic groups could not be observed due to the fast exchange with traces of water 
present in the deuterated solvents. The resolution of 13C spectra was increased when necessary by 
performing an exponential apodization of the FID.  
Mass spectrometry (MS): All the mass analysis were performed by using electrospray techniques 
(ESI). High-Resolution mass spectrometry measurements were performed on a JEOL AccuTOF 
instrument by using water, acetonitrile or methanol as solvents. Standard mass spectrometry 
measurements were performed on a FINNIGAN LCQ Advantage Max by using water, acetonitrile or 
methanol as solvents. 
High-performance liquid chromatography (HPLC): High-performance liquid chromatography (HPLC) 
was carried out on a Shimadzu LC-20AT HPLC system equipped with a UV-Vis detector SPD-10AV 
and a fraction collector. Columns were purchased from Dr. Maisch GmbH. The compounds were 
purified on mg scale using a semipreparative reversed-phase HPLC column. A 2 mL solution was 
injected in a column ReproSil 100 C8, 5 μ (250X10 mm) operating at 30 °C. The detection 
wavelengths were fixed at 254 and 215 nm. A gradient of H2O and acetonitrile both containing either 
0.1% v/v HCl or TFA was used as mobile phase, with a flow rate of 4 mL min-1. HCl was used to 
ensure that the chloride was the only counterion of the isolated compounds. In all cases the samples 
were prepared by dissolving the compound in mixtures H2O/acetonitrile 95/5 or 1/1 v/v, and filtered 
on a nylon syringe filter (0.2 μm).  
X-ray crystallography: Single crystals of 1 (phtl-Me) and 2 (phtl-ada) were grown by slow evaporation 
of a solution of compounds 1 and 2 in CHCl3/heptane. Single crystals of pytl-DC were grown by slow 
evaporation of a solution of pytl-DC in CH3OH. Single crystals of 6a and 7a were grown by slow 
evaporation of a slightly acidic solution of 6a and 7a in H2O/acetonitrile. The crystal data and 
summaries of the data collection and structure refinement are given in Table S1 for compounds 1 and 
2, and Table S2 for 6a, 7a, and pytl-DC; selected distances and bond angles as well as atomic 
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coordinates and equivalent isotropic displacement parameters for the non-hydrogen atoms are also 
given in the Supplementary Information. All measurements were performed at -65 °C. The structures 
of 1, 6a, and 7a were solved by the program SHELXS [38], those of 2 and pytl-DC by the program 
CRUNCH [39]. All non-hydrogen atoms were refined with anisotropic temperature factors. The 
hydrogen atoms were placed at calculated positions, and refined isotropically in riding mode. 
Crystallographic data (excluding structure factors) for the structures reported in this paper have been 
deposited with the Cambridge Crystallographic Data Centre as supplementary publication CCDC-
1003/, deposition codes: 1 (FELIC3), 757888; 2 (MFR130), 757886; 6a (MFR99), 757884; 7a 
(MFR99B), 757885; pytl-DC (PYTLUD), 757887. Copies of available material can be obtained, free 
of charge, on application to the Director, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK, (fax: +44-
(0) 1223-336033 or e-mail:teched@chemcrys.cam.ac.uk). 
Emission and UV-vis: Electronic absorption spectra were recorded in a quartz cuvette (1 cm, Hellma) 
on Hewlett-Packard 8543 diode array spectrometer (range 190 nm-1100 nm). Steady state fluorescence 
spectra were recorded using a Spex 1681 fluorimeter, equipped with a Xe arc light source, a 
Hamamatsu R928 photomultiplier tube detector and double excitation and emission monochromator. 
Emission spectra were corrected for source intensity and detector response by standard correction 
curves, unless otherwise noted. Luminescence quantum yields (Φem) were measured in optically dilute 
solutions (O.D. < 0.1 at excitation wavelength), using [Ru(bpy)3]Cl2 in aerated and deoxygenated H2O 
(Φem, air = 0.028; Φem, deox = 0.042) or diphenylanthracene in aerated and deoxygenated cyclohexane 
(Φem, air = 0.77; Φem, deox = 0.91) as references.  
Lifetimes of excited states were determined using a coherent Infinity Nd:YAG-XPO laser (2 ns 
pulses fwhm) and a Hamamatsu C5680-21 streak camera equipped with Hamamatsu M5677 low speed 
single sweep unit. Streak cameras are high-speed light detectors, which enable detection of the 
fluorescence as a function of the spectral and the time evolution simultaneously.  
4.2. Synthesis and characterization 
1-Methyl-4-phenyl-1H-1,2,3-triazole (1): Dry DMF was deoxygenated prior to use by performing three 
freeze-pump-thaw cycles. A two-necked round bottom flask was carefully dried with flame, under N2 
flow. In the cooled flask, NaN3 (198 mg, 3 mmol) was added together with deoxygenated dry DMF 
(40 mL). CH3I (0.3 mL, 4.8 mmol) was added dropwise and the solution was stirred in the dark 
overnight. The methyl-azide formed is a highly explosive intermediate and therefore it was not isolated 
[40]. The ‘clicking’ reagents were subsequently added to the reaction mixture and a large excess of 
ethynylbenzene (658.9 μL, 6 mmol) and of catalyst were used to ensure the complete consumption of 
the methyl-azide. A solution of CuBr (430 mg, 3 mmol) and PMDTA (0.67 mL, 3.2 mmol) was 
prepared by dissolving both reagents in oxygen-free dry DMF (10 mL), bubbling nitrogen through the 
solution for 20 min to prevent oxidation of Cu(I). When the CuPMDTA complex dissolved, an aliquot 
of the solution (5 mL), together with compound ethynylbenzene (0.45 mL, 4.5 mmol) were added to 
the flask. The resulting mixture was stirred in the dark at room temperature under a nitrogen 
atmosphere for 24 hours. The reaction was followed by TLC (eluent: Et2O). After removal of the 
solvent in vacuo (CAUTION: this solution may still contain methyl azide in case the conversion with 
phenylacetylene was not 100 %) the solid obtained was purified by column chromatography 
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(Et2O/Heptane 50/50 followed by Et2O/ethyl acetate 90/10). Product 1 was obtained as a white solid 
(208 mg, overall yield 43%). Crystals were grown by slow evaporation of a solution of 1 in 
CHCl3/heptane. The structure was further confirmed by X-ray single crystal diffraction. 1H-NMR (300 
MHz, CDCl3): δ ppm 7.86–7.78 (m, 2H), 7.73 (s, 1H), 7.47–7.38 (m, 2H), 7.37–7.29 (m, 1H), 4.14 (s, 
3H); 13C-NMR (75 MHz, CDCl3): δ ppm 148.0, 130.6, 128.8, 128.1, 125.7, 120.5, 36.7; HRMS (ES+, 
CHCl3/CH3OH): m/z calcd for C9H10N3: 160.08747; found: 160.08768 [M+H]+. 
 
1-Adamantyl-4-phenyl-1H-1,2,3-triazole (2): Distilled THF was bubbled with N2 for 1h prior to use in 
order to remove the oxygen. Ethynylbenzene (185.6 μL, 1.69 mmol) and 1-adamantylazide (300 mg, 
1.69 mmol) were added under nitrogen atmosphere in a Schlenk tube and dissolved in deoxygenated 
THF (15 mL). A solution of CuBr (242.4 mg, 1.69 mmol) and PMDTA (365.8 μL, 1.75 mmol) was 
prepared by dissolving both reagents in deoxygenated THF (15 mL) and bubbling nitrogen through the 
solution for 20 min to prevent oxidation of Cu(I). When the CuPMDTA complex dissolved, the 
solution became slightly green, and an aliquot of it (3 mL) was added to the Schlenk tube. The 
resulting mixture was stirred in the dark, at room temperature under a nitrogen atmosphere for  
2.5 hours. The reaction was followed by TLC (eluent: Et2O/heptane 80/20). No workup was done and 
after removal of the solvent in vacuo, the blue-green solid obtained was directly purified by column 
chromatography (Et2O/heptane 30/70). Product 2 was obtained as a white solid (358.8 mg, 76%). 
Crystals were grown by slow evaporation of a solution of 2 in CHCl3/heptane. The structure was 
further confirmed by X-ray single crystal diffraction. 1H-NMR (300 MHz, CDCl3): δ ppm 7.86–7.81 
(m, 2H), 7.82 (s, 1H), 7.45–7.38 (m, 2H), 7.34–7.28 (m, 1H), 2.32–2.26 (m, 9H), 1.85–1.79 (m, 6H); 
13C-NMR (75 MHz, CDCl3): δ ppm 137.8, 131.1, 128.8, 127.8, 125.6, 118.2, 59.6, 43.0, 35.9, 29.5; 
HRMS (ES+, CHCl3/CH3OH): m/z calcd for C18H22N3: 280.18137; found: 280.18165 [M+H]+. 
3α,7β-Dihydroxy-5β-cholan-24-oic acid methyl ester (3): Ursodeoxycholic acid (UDC, 277.1 mg,  
0.71 mmol) was dissolved in methanol (10 mL). A catalytic amount of p-toluensolfonic acid was 
added and the solution was stirred under reflux for 2.5 hours. The reaction was followed by TLC 
(eluent: ethyl acetate/heptane 80/20). After removal of the solvent in vacuo, the crude product was 
dissolved in CHCl3 and washed with aqueous solution of K2CO3 (1M, 1 × 100 mL). The organic phase 
was dried over Na2SO4 anhydrous and the solvent removed under reduced pressure to yield 3 as a 
white solid (282.3 mg, 98%). 1H-NMR (300 MHz, CDCl3): δ ppm 3.64 (s, 3H), 3.61–3.48 (m, 2H), 
2.41–2.10 (m, 2H), 2.01–0.96 (m, 24H), 0.92 (s, 3H), 0.90 (d, J = 6.4 Hz, 3H), 0.65 (s, 3H); 13C-NMR 
(75 MHz, CDCl3): δ ppm 174.7, 71.3, 71.2, 55.7, 54.9, 51.4, 43.69, 43.66, 42.4, 40.1, 39.2, 37.3, 36.9, 
35.2, 34.9, 34.0, 31.01, 30.96, 30.3, 28.5, 26.8, 23.3, 21.1, 18.3, 12.1. 
Mixture of 3α-(4-Methylphenyl)sulfonyloxy-7β-hydroxy-5β-cholan-24-oic acid methyl ester (4) and 
3α-hydroxy-7β-(4-Methylphenyl)sulfonyloxy-5β-cholan-24-oic acid methyl ester (5): Compound 3 
(254.5 mg, 0.62 mmol) was added under nitrogen atmosphere in a Schlenk tube and dissolved in dry 
pyridine (5 mL). Tosyl chloride (178.4 mg, 0.94 mmol) was added and the solution was heated to  
50 ºC under nitrogen for 4 hours. The reaction was followed by TLC (eluent: ethyl acetate/heptane 
50/50). After removal of the solvent in vacuo, the crude product was dissolved in ethyl acetate, washed 
with HCl (1N, 3 × 80 mL) and water (1 × 80 mL). The organic phase was dried over Na2SO4 
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anhydrous and the solvent removed under reduced pressure. The crude product (348.4 mg) was further 
reacted without purification. 
3α-Hydroxy-7α-azido-5β-cholan-24-oic acid methyl ester (6) and 3β-azido-7β-hydroxy-5β-cholan-24-
oic acid methyl ester (7): The crude material containing compounds 4+5 (348.4 mg) was added under 
nitrogen atmosphere in a Schlenk tube and dissolved in dry DMF (15 mL). Sodium azide (201.5 mg, 
3.1 mmol) was added and the solution was heated to 60 ºC under nitrogen for 20 hours. The reaction 
was followed by TLC (eluent: ethyl acetate/heptane 50/50). After removal of most of the solvent in 
vacuo, the crude material was dissolved in ethyl acetate and washed with water (2 × 80 mL). The 
organic phase was dried over Na2SO4 anhydrous and the solvent removed under reduced pressure. The 
crude material was purified by column chromatography (eluent: ethyl acetate/heptane 15/85). Product 
6 was obtained as a slightly yellow viscous oil (48.2 mg, overall yield = 18%). Product 7 was obtained 
as a slightly yellow viscous oil (72.8 mg, overall yield = 27.2%). 
 
6: 1H-NMR (300 MHz, CDCl3): δ ppm 3.73–3.68 (m, 1H), 3.66 (s, 3H), 3.55–3.43 (m, 1H), 2.43–0.95 
(m, 26H), 0.92 (d, J = 6.1 Hz, 3H), 0.91 (s, 3H), 0.63 (s, 3H); 13C-NMR (75 MHz, CDCl3): δ ppm 
174.7, 71.8, 60.5, 55.6, 51.5, 51.1, 42.6, 41.0, 39.3, 38.3, 38.2, 35.3, 35.2, 34.9, 33.7, 31.0, 30.9, 30.6, 
30.4, 28.0, 23.3, 22.9, 20.4, 18.3, 11.7.  
 
7: 1H-NMR (300 MHz, CDCl3): δ ppm 3.93–3.88 (m, 1H), 3.66 (s, 3H), 3.59–3.46 (m, 1H), 2.41–2.15 
(m, 2H), 2.04–0.99 (m, 24H), 0.97 (s, 3H), 0.92 (d, J = 6.4 Hz, 3H), 0.67 (s, 3H); 13C-NMR (75 MHz, 
CDCl3): δ ppm 174.6, 71.3, 58.3, 55.8, 54.9, 51.5, 43.7, 43.6, 40.1, 38.9, 37.8, 36.3, 35.2, 34.4, 31.2, 
31.01, 30.98, 30.3, 28.5, 26.8, 24.5, 23.7, 21.3, 18.3, 12.1. 
 
3α-Hydroxy-7α-azido-5β-cholan-24-oic acid (6a) and 3β-azido-7β-hydroxy-5β-cholan-24-oic acid 
(7a): A solution of NaOH was prepared by adding an aqueous solution of NaOH (2 N, 2 mL) into 
CH3OH (7 mL). 6a (20 mg, 0.046 mmol) or 7a (20 mg, 0.046 mmol) were dissolved in this solution 
and the resulting mixture was stirred at room temperature overnight. The reaction was followed by 
TLC (eluent: ethyl acetate). While cooling the reaction in ice bath, HCl (4 N) was added until pH = 7. 
After removal of the solvent in vacuo, the crude material obtained was purified by column 
chromatography (eluent: ethyl acetate). Product 6a was obtained as a white solid (18.6 mg, 97%). 
Product 7a was obtained as a white solid (19 mg, 99%). Single crystals of 6a and 7a were grown by 
slow evaporation of their slightly acidic solution in H2O/acetonitrile. The structures were further 
confirmed by X-ray single crystal diffraction. Alternatively, compounds 6a and 7a could be isolated 
from the crude mixture by semipreparative HPLC equipped with a reversed-phase column. The mobile 
phase was a gradient of H2O and acetonitrile (30% to 0% v/v of H2O in 35 min) both containing 0.1% 
v/v TFA, with a flow rate of 4 mL min-1. 
 
6a: 1H-NMR (300 MHz, CDCl3): δ ppm 3.73–3.68 (m, 1H), 3.56–3.44 (m, 1H), 2.46–0.95 (m, 26H), 
0.95–0.90 (m, 6H), 0.64 (s, 3H); 13C-NMR (75 MHz, CDCl3): δ ppm 179.0, 71.8, 60.4, 55.6, 51.1, 
42.6, 41.0, 39.3, 38.3, 38.1, 35.3, 35.2, 34.9, 33.7, 30.8, 30.7, 30.6, 30.4, 28.0, 23.6, 22.9, 20.5, 18.2, 
11.8. 
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7a: 1H-NMR (300 MHz, CDCl3): δ ppm 3.93–3.89 (m, 1H), 3.57–3.45 (m, 1H), 2.45–2.22 (m, 2H), 
2.04–1.0 (m, 24H), 0.98 (s, 3H), 0.94 (d, J = 6.4 Hz, 3H), 0.69 (s, 3H); 13C-NMR (75 MHz, CDCl3): δ 
ppm 178.8, 71.4, 58.3, 55.8, 54.9, 43.8, 43.6, 40.1, 38.9, 37.9, 36.3, 35.2, 34.5, 31.3, 30.8, 30.3, 29.7, 
28.6, 26.8, 24.6, 23.8, 21.4, 18.4, 12.1. 
3β-(4'-(Pyridin-6'-yl)-1'H-1',2',3'-triazol-1'-yl)-7β-hydroxy-5β-cholan-24-oic acid methyl ester (8) 
(Scheme 5): Distilled THF was bubbled with N2 for 1 hour prior to use in order to remove the oxygen. 
2-Ethynylpyridine (58.6 μL, 0.58 mmol) and 7 (250 mg, 0.58 mmol) were added under nitrogen 
atmosphere in a Schlenk tube and dissolved in deoxygenated THF (10 mL). A solution of CuBr  
(83.2 mg, 0.58 mmol) and PMDTA (125.4 μL, 0.6 mmol) was prepared by dissolving both reagents in 
deoxygenated THF (10 mL) and bubbling nitrogen through the solution for 20 min to prevent 
oxidation of Cu(I). When the CuPMDTA complex dissolved, the solution became slightly green, and 
an aliquot of it (4 mL) was added to the Schlenk tube. The resulting mixture was stirred in the dark, at 
room temperature under a nitrogen atmosphere for 24 hours. The reaction was followed by TLC 
(eluent: ethyl acetate). After removal of the solvent in vacuo, the blue-green solid obtained was 
directly purified by column chromatography (eluent: ethyl acetate/heptane 50/50 followed by ethyl 
acetate/heptane 60/40). Product 8 was obtained as a white solid (303.9 mg, 98%). 1H-NMR (400 MHz, 
CDCl3): δ ppm 8.57 (ddd, J = 4.9, 1.7, 0.9 Hz, 1H), 8.24 (s, 1H), 8.20 (ddd, J = 8.0, 1.0, 1.0, Hz, 1H), 
7.77 (ddd, J = 7.8, 7.8, 1.8 Hz, 1H), 7.22 (ddd, J = 7.6, 4.9, 1.1 Hz, 1H), 4.72–4.68 (m, 1H), 3.66 (s, 
3H), 3.67–3.57 (m, 1H), 2.40–1.02 (m, 26H), 0.94–0.91 (m, 6H), 0.68 (s, 3H); 13C-NMR (75 MHz, 
CDCl3): δ ppm 174.5, 150.3, 149.1, 147.6, 136.8, 122.6, 121.0, 120.1, 70.9, 56.5, 55.8, 54.8, 51.3, 
43.5, 43.2, 39.9, 39.4, 37.6, 36.2, 35.1, 34.2, 30.94–30.77 (m), 30.4, 28.4, 26.7, 24.8, 23.4, 21.3, 18.2, 
12.0; HRMS (ES+, CH3OH): m/z calcd for C32H46N4NaO3: 557.34676; found: 557.34578 [M+Na]+. 
Scheme 5. Structure and atom labeling of 8. 
 
 
 
3β-(4'-(Pyridin-6'-yl)-1'H-1',2',3'-triazol-1'-yl)-7β-hydroxy-5β-cholan-24-oic acid (pytl-DC) (Scheme 
6): A solution of NaOH was prepared by adding an aqueous solution of NaOH (2 N, 2 mL) into 
CH3OH (7 mL). 8 (55.9 mg, 0.10 mmol) was dissolved in this solution and the resulting mixture was 
stirred at room temperature overnight. The reaction was followed by TLC (eluent: CH3OH/ethyl 
acetate 10/90). While cooling the reaction in ice bath, HCl (4 N) was added until pH=7–8. After 
removal of the solvent in vacuo, the crude material obtained was purified by column chromatography 
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(CH3OH/ethyl acetate 10/90). Pytl-DC was obtained as a white solid (55.6 mg, 98%). Crystals were 
grown by slow evaporation of a solution of pytl-DC in CH3OH. The structure was further confirmed 
by X-ray single crystal diffraction. 1H-NMR (300 MHz, DMSO-d6): δ ppm 8.67 (s, 1H), 8.59 (ddd,  
J = 4.9, 1.8, 1.0 Hz, 1H), 8.05 (ddd, J = 8.0, 1.1, 1.1 Hz, 1H), 7.89 (ddd, J = 8.0, 7.8, 1.8 Hz, 1H), 7.33 
(ddd, J = 7.7, 4.9, 1.1 Hz, 1H), 4.74–4.68 (m, 1H), 3.44–3.32 (m, 1H), 2.29–0.93 (m, 26H), 0.89 (d, J 
= 6.4 Hz, 3H), 0.85 (s, 3H), 0.63 (s, 3H); 13C-NMR (75 MHz, DMSO-d6): δ ppm 175.8, 150.7, 149.9, 
147.4, 137.6, 123.3, 122.9, 119.9, 69.8, 56.6, 56.2, 55.3, 43.5, 43.2, 40.2, 39.3, 38.1, 37.2, 35.3, 34.4, 
31.6, 31.4, 31.0, 30.7, 28.6, 27.1, 24.8, 24.0, 21.6, 18.8, 12.5; HRMS (ES+, CH3OH): m/z calcd for 
C31H44N4NaO3: 543.33111; found: 543.33058 [M+Na]+. 
Scheme 6. Structure and atom labeling of pytl-DC. 
 
 
[(1)2Ir-µ-Cl]2: A mixture 3/1 of 2-methoxyethanol/water (9 mL) was deoxygenated by bubbling 
nitrogen through it for 10-15 min. The ligand 1 (91.5 mg, 0.57 mmol) and IrCl3⋅3H2O (70 mg,  
0.23 mmol) were added and the solution was heated to 97 ºC in the dark for 24 hours, under nitrogen 
atmosphere (without bubbling). After cooling to room temperature, the yellow solid was filtered off, 
washed with water (3 × 100 mL), diethyl ether (3 × 100 mL) and dried. After purification by column 
chromatography (eluent: from MeOH/CHCl3 5/95 to MeOH/CHCl3 10/90), the chloride-bridged 
complex [(1)2Ir-µ-Cl]2 was obtained as a yellow solid (97.4 mg, 78%). 1H-NMR (400 MHz, DMSO-
d6): δ ppm 8.61 (s, 2H), 8.59 (s, 2H), 7.42 (ddd, J = 7.4, 1.4, 0.5 Hz, 2H), 7.41 (ddd, J = 7.5, 1.4, 0.5 
Hz, 2H), 6.81 (ddd, J = 7.4, 7.4, 1.2 Hz, 2H), 6.80 (ddd, J = 7.4, 7.4, 1.2 Hz, 2H), 6.64 (ddd, J = 7.4, 
7.4, 1.4 Hz, 2H), 6.63 (ddd, J = 7.4, 7.4, 1.5 Hz, 2H), 6.05 (ddd, J = 7.6, 1.2, 0.5 Hz, 2H), 6.00 (ddd,  
J = 7.6, 1.2, 0.5 Hz, 2H), 4.30–4.26 (m, 12H). ESI-MS (ES+, CHCl3/CH3OH): m/z = 1053.1 [M-Cl]+. 
[(2)2Ir-µ-Cl]2: A mixture 3/1 of 2-methoxyethanol/water (9 mL) was deoxygenated by bubbling 
nitrogen through it for 10-15 min. The ligand 2 (50 mg, 0.18 mmol) and IrCl3⊕3H2O (21.4 mg,  
0.072 mmol) were added and the solution was heated to 97 ºC in the dark for 24 hours, under nitrogen 
atmosphere (without bubbling). After cooling to room temperature, the yellow solid was filtered off, 
washed with water (3 × 80 mL) and dried. After purification by column chromatography (eluent: ethyl 
acetate), the chloride-bridged complex [(2)2Ir-µ-Cl]2 was obtained as a yellow solid (35 mg, 62%). 1H- 
NMR (400 MHz, CDCl3): δ ppm 7.83 (s, 2H), 7.77 (s, 2H), 7.27–7.22 (m, 4H), 6.75 (ddd, J = 7.4, 7.4, 
1.1 Hz, 2H), 6.70 (ddd, J = 7.3, 7.3, 1.2 Hz, 2H), 6.64 (ddd, J = 7.2, 7.2, 1.1 Hz, 2H), 6.62 (ddd,  
J = 7.3, 7.3, 1.2 Hz, 2H), 6.15 (dd, J = 7.4, 0.8 Hz, 2H), 6.04 (dd, J = 7.6, 0.5 Hz, 2H), 2.48–2.28 (m, 
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36H), 1.90–1.79 (m, 24H); 13C-NMR (75 MHz, CDCl3): δ ppm 157.0, 156.8, 145.9, 143.9, 136.3, 
135.8, 132.9, 132.3, 127.24, 127.22, 121.08, 121.06, 120.8, 120.6, 113.9, 113.7, 61.9, 61.4, 42.9, 42.8, 
35.79, 35.75, 29.49, 29.46; ESI-MS (ES+, CHCl3/CH3OH): m/z = 807.0 [(M/2)+Na]+ 
[(1)(2)Ir-µ-Cl]2: A mixture 3/1 of 2-methoxyethanol/water (12 mL) was deoxygenated by bubbling 
nitrogen through it for 10-15 min. The ligands 1 (40 mg, 0.25 mmol) and 2 (70.2 mg, 0.25 mmol), and 
IrCl3⊕3H2O (62.5 mg, 0.21 mmol) were added and the solution was heated to 97 ºC in the dark for  
24 hours, under nitrogen atmosphere (without bubbling). After cooling to room temperature, the 
yellow solid was filtered off, washed with water (3 × 80 mL) and dried. This reaction is expected to 
yield a mixture of chloride-bridged complexes [(X)(Y)Ir-µ-Cl]2 (X=Y=1,2). The reaction was followed 
by TLC (eluent: CH3OH/CHCl3 20/80) where several spots, corresponding to different dimeric 
species, could be observed. The crude material was further reacted without purification. 
[Ir(1)2(pytl-Me)]Cl: To a suspension of the precursor [(1)2Ir-µ-Cl]2 (47.2 mg, 0.043 mmol) in 
MeOH/CHCl3 1/3 v/v (4 mL) was added pytl-Me as a solid (14.6 mg, 0.086 mmol). The suspension 
was heated to 45 ºC and stirred in the dark for 3 hours, after which time a clear and yellow solution 
was obtained. The reaction was followed by TLC (eluent: MeOH/CHCl3 30/70) where, under UV light 
at 366 nm, the compound appeared as a bright green-blue luminescent spot. After removal of the 
solvent in vacuo, the solid obtained was purified by PLC (eluent: MeOH/CHCl3 25/75). The product 
was obtained as a slightly yellow solid (47.4 mg, 80%). 1H-NMR (400 MHz, CDCl3): δ ppm 10.48 (s, 
1H), 8.88 (d, J = 7.9 Hz, 1H), 7.93-7.87 (m, 2H), 7.77 (s, 1H), 7.73 (s, 1H), 7.43 (dd, J = 7.5, 1.1 Hz, 
1H), 7.39 (dd, J = 7.4, 1.1 Hz, 1H), 7.12 (ddd, J = 7.5, 5.6, 1.3 Hz, 1H), 6.96 (ddd, J = 7.5, 7.5, 1.2 Hz, 
1H), 6.92 (ddd, J = 7.4, 7.4, 1.2 Hz, 1H), 6.85 (ddd, J = 7.5, 7.5, 1.4 Hz, 1H), 6.81 (ddd, J = 7.5, 7.5, 
1.4 Hz, 1H), 6.32–6.28 (m, 2H), 4.16 (s, 3H), 4.08 (s, 3H), 4.05 (s, 3H); 13C-NMR (75 MHz, CDCl3): δ 
ppm 157.9, 157.5, 151.1, 150.3, 149.3, 146.1, 142.3, 139.0, 135.3, 135.0, 132.75, 132.73, 128.9, 128.6, 
128.1, 124.8, 123.7, 122.6, 122.3, 122.2, 122.1, 118.9, 118.8, 38.60, 38.56, 38.5; HRMS (ES+, 
CH3OH): m/z calcd for C26H24IrN10: 669.18146; found: 669.18464 M+. 
[Ir(2)2(pytl-ada)]Cl: To a suspension of the precursor [(2)2Ir-µ-Cl]2 (20.0 mg, 0.013 mmol) in 
MeOH/CHCl3 1/3 v/v (4 mL) was added pytl-ada as a solid (7.29 mg, 0.026 mmol). The suspension 
was heated to 45 ºC and stirred in the dark for 3 hours, after which time a clear and yellow solution 
was obtained. The reaction was followed by TLC (eluent: MeOH/CHCl3 20/80) where, under UV light 
at 366 nm, the compound appeared as a bright green-blue luminescent spot. After removal of the 
solvent in vacuo, the solid obtained was purified by column chromatography (eluent: from CHCl3 to 
MeOH/CHCl3 5/95). The product was obtained as a slightly yellow solid (20.3 mg, 76%). 1H-NMR 
(400 MHz, CDCl3): δ ppm 10.56 (s, 1H), 9.16 (d, J = 7.8 Hz, 1H), 7.96 (bd, J = 5.4 Hz, 1H), 7.92 
(ddd, J = 7.8, 7.8, 1.4 Hz, 1H), 7.76 (s, 1H), 7.71 (s, 1H), 7.34 (dd, J = 5.7, 1.3 Hz, 1H), 7.32 (dd,  
J = 5.6, 1.2 Hz, 1H), 7.07 (ddd, J = 7.2, 5.8, 1.2 Hz, 1H), 6.91 (ddd, J = 6.7, 6.7, 1.2 Hz, 1H), 6.88 
(ddd, J = 6.6, 6.6, 1.2 Hz, 1H), 6.82 (ddd, J = 7.4, 7.4, 1.4 Hz, 1H), 6.77 (ddd, J = 7.5, 7.5, 1.4 Hz, 
1H), 6.16 (dd, J = 7.6, 0.6 Hz, 1H), 6.13 (dd, J = 7.5, 0.6 Hz, 1H), 2.30–2.19 (m, 15H), 2.13–2.10 (m, 
12H), 1.81–1.68 (m, 18H); 13C-NMR (75 MHz, CDCl3): δ ppm 156.7, 156.1, 151.7, 150.0, 148.9, 
146.8, 143.3, 138.9, 136.1, 135.7, 133.0, 132.3, 128.2, 127.4, 125.2, 124.01, 123.95, 122.1, 121.7, 
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121.5, 121.2, 114.1, 114.0, 62.2, 61.9, 61.8, 42.70, 42.67, 42.5, 35.67, 35.63, 29.7, 29.5, 29.37, 29.36; 
HRMS (ES+, CH3OH): m/z calcd for C53H60IrN10: 1029.46316; found: 1029.46242 M+. 
[Ir(1)(2)(pytl-ada)]Cl: To a suspension of the crude mixture of the precursors [(X)(Y)Ir-µ-Cl]2 
(X=1,2; Y=1,2) (76.2 mg) in MeOH/CHCl3 1/3 v/v (8 mL) was added pytl-ada as a solid (44.8 mg, 
0.16 mmol). The suspension was heated to 45 ºC and stirred in the dark for 3 hours, after which time a 
yellow solution was obtained. The reaction was followed by TLC (eluent: MeOH/CHCl3 20/80). The 
mixture of products obtained could not be separated by column chromatography. After removal of the 
solvent in vacuo, the crude material was purified by using a semipreparative HPLC equipped with a 
reversed-phase column. The mobile phase was a gradient of H2O and acetonitrile (50% for 20 min + 
gradient 50% to 100% v/v of acetonitrile in 40 min) both containing 0.1% v/v HCl. The complex 
[Ir(1)(2)(pytl-ada)]Cl exists in four stereoisomeric forms: the two diastereoisomers A and B  
(Scheme 7), and their corresponding enantiomers (Λ,Δ). The diastereoisomeric species A(Λ+Δ) and 
B(Λ+Δ) could be separated by HPLC in the conditions described above. However, we did not perform 
their isolation and collected them as a mixture. The HPLC fractions containing the desired iridium 
complex were identified by ESI-MS. The retention time of the two peaks of [Ir(1)(2)(pytl-ada)]Cl were 
t = 41.9 min and t = 43.3 min. After collecting the fractions, the solvent was removed in vacuo at  
40 ºC. The product was obtained as a slightly yellow solid (21.1 mg, overall yield = 11%) containing 
the two diastereoisomers in a ratio 1:0.8 as calculated from the NMR spectrum. 1H-NMR (400 MHz, 
CDCl3): δ ppm 10.49 (s, 0.8H), 10.45 (s, 1H), 9.12–9.05 (m, 1H+0.8H), 7.93–7.83 (m, 2H+1.6H), 7.77 
(bs, 1.6H), 7.76 (s, 1H), 7.73 (s, 1H), 7.33 (dd, J = 7.4, J = 1.1 Hz, 1.6H), 7.32 (dd, J = 7.2, J = 1.1 Hz, 
1H), 7.29 (dd, J = 7.4, J = 1.2 Hz, 1H), 7.08–7.02 (m, 1H+0.8H), 6.92–6.76 (m, 3H+2.4H), 6.75 (ddd, 
J = 7.4, J = 7.4, J = 1.3 Hz, 0.8H) 6.74 (ddd, J = 7.4, J = 7.4, J = 1.3 Hz, 1H), 6.31 (d, J = 7.5 Hz, 
0.8H), 6.24 (d, J = 7.5 Hz, 1H), 6.12 (d, J = 7.5 Hz, 1H), 6.08 (d, J = 7.5 Hz, 0.8H), 4.02 (s, 2.4H), 
4.00 (s, 3H), 2.28–2.22 (m, 9H+7.2H), 2.22–2.17 (m, 3H+2.4H), 2.14–2.09 (m, 6H+4.8H), 1.82–1.66 
(m, 12H+9.6H); 13C-NMR (75 MHz, CDCl3): δ ppm 157.8, 157.2, 156.6, 156.0, 151.48, 151.47, 150.1, 
149.9, 148.84, 148.79, 146.5, 146.2, 143.2, 142.9, 138.9–138.8 (m), 135.9, 135.63, 135.60, 135.4, 
133.1, 132.9, 132.4, 132.2, 128.2, 128.1, 127.5, 127.3, 125.1, 124.9, 124.3, 124.2, 123.7, 123.6, 
122.23, 122.19, 122.1, 121.8, 121.7, 121.56, 121.55, 121.3, 119.2, 119.0, 114.3, 114.1, 62.4, 62.3, 
61.9, 61.8, 42.62, 42.57, 42.4, 42.3, 38.5, 38.4, 35.60, 35.58, 35.55, 29.41–29.37 (m), 29.32, 29.30; 
HRMS (ES+, CH3OH): m/z calcd for C44H48IrN10: 909.36926; found: 909.37012 M+. 
Scheme 7. Structure of the diastereoisomers A and B of [Ir(1)(2)(pytl-ada)]Cl. 
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[Ir(1)2(pytl-DC)]Cl: To a suspension of the precursor [(1)2Ir-µ-Cl]2 (28.3 mg, 0.026 mmol) in 
MeOH/CHCl3 1/3 v/v (4 mL) was added pytl-DC as a solid (26.8 mg, 0.052 mmol). The suspension 
was heated to 45 ºC and stirred in the dark for 17 hours, after which time a clear and yellow solution 
was obtained. The reaction was followed by TLC (eluent: MeOH/CHCl3 20/80) where, under UV light 
at 366 nm, the compound appeared as a bright green-blue luminescent spot. After removal of the 
solvent in vacuo, the solid obtained was purified by PLC (eluent: MeOH/CHCl3 20/80). The product 
was obtained as a slightly yellow solid (39.1 mg, 73%) containing a mixture 1:1 of two 
diastereoisomers as also confirmed by the NMR spectrum. 1H-NMR (400 MHz, CD3OD): δ ppm 9.041 
(s, 1H), 9.038 (s, 1H), 8.24–8.23 (m, 1H), 8.23 –8.22 (m, 3H), 8.20–8.16 (m, 2H), 8.08–7.99 (m, 4H), 
7.50–7.46 (m, 2H), 7.44–7.40 (m, 2H), 7.34–7.30 (m, 2H), 6.97–6.92 (m, 2H), 6.88–6.79 (m, 4H), 6.71 
(ddd, J = 7.4, J = 1.4, J = 1.4 Hz, 2H), 6.29 (ddd, J = 7.5, J = 1.1, J = 0.5 Hz, 1H), 6.28 (ddd,  
J = 7.6, J = 1.1, J = 0.5 Hz, 1H), 6.25–6.22 (m, 2H), 4.81–4.76 (m, 2H), 4.07–4.06 (m, 6H), 4.05 (bs, 
6H), 3.51–3.42 (m, 2H), 2.37–0.89 (m, 64H), 0.72 (s, 6H); HRMS (ES+, CH3OH): m/z calcd for 
C49H60IrN10O3: 1029.44791; found: 1029.44633 M+. 
[Ir(1)2(pytl-βCD)]Cl: To a suspension of the precursor [(1)2Ir-µ-Cl]2 (7.04 mg, 0.006 mmol) in 
MeOH/CHCl3 1/3 v/v (4 mL) was added pytl-βCD as a solid (20.1 mg, 0.013 mmol). The suspension 
was heated to 45 ºC and stirred in the dark for 3 hours, after which time a clear and yellow solution 
was obtained. The reaction was followed by TLC (eluent: MeOH/CHCl3 15/85) where, under UV light 
at 366 nm, the compound appeared as a bright green-blue luminescent spot. After removal of the 
solvent in vacuo, the solid obtained was purified by column chromatography (eluent: MeOH/CHCl3 
5/95). The product was obtained as a slightly yellow solid (16.0 mg, 59%) containing a mixture 1:1 of 
two diastereoisomers as also confirmed by the NMR spectrum. 1H-NMR (300 MHz, CDCl3): δ ppm 
9.73 (s, 1H), 9.63 (s, 1H), 8.87–8.68 (m, 2H), 7.95–7.87 (m, 2H), 7.81 (s, 1H), 7.78 (s, 1H), 7.744 (s, 
1H), 7.736 (s, 1H), 7.40–7.21 (m, 6H), 7.17–7.11 (m, 2H), 6.97–6.65 (m, 8H), 6.30–6.21 (m, 2H), 
6.17–6.06 (m, 2H), 5.57–5.46 (m, 1H), 5.39–5.03 (m, 13H), 4.95–4.83 (m, 1H), 4.78–4.69 (m, 1H), 
4.17 (s, 3H), 4.12 (s, 3H), 4.11 (s, 3H), 4.05 (s, 3H), 4.15–2.98 (m, 200H), 2.96–2.89 (m, 1H),  
2.81–2.74 (m, 1H); HRMS (ES+, CH3OH): m/z calcd for C87H130IrN10O34: 2051.83801; found: 
2051.83965 M+. 
Acknowledgements 
The authors thank the European Union for support through the Marie Curie Research and Training 
Network UNI-NANOCUPS. M.F. acknowledges University “La Sapienza” of Rome for a scholarship. 
R.J.M.N. acknowledges the Royal Netherlands Academy of Science and Art for financial support. 
References and Notes 
1. Holder, E.; Langeveld, B.M.W.; Schubert, U.S. New trends in the use of transition metal-ligand 
complexes for applications in electroluminescent devices. Adv. Mater. 2005, 17, 1109–1121. 
2. Yersin, H. Triplet emitters for OLED applications. Mechanisms of exciton trapping and control of 
emission properties. Top. Curr. Chem. 2004, 241, 1–26. 
Molecules 2010, 15                            
 
 
2057
3. Neve, F.; Crispini, A. Metal-containing amphiphiles: Orthometallated Iridium(III) complexes 
with substituted 6'-phenyl-2,2'-bipyridines. Eur. J. Inorg. Chem. 2000, 1039–1043. 
4. Lo, K.K.; Zhang, K.Y.; Leung, S.K.; Tang, M.C. Exploitation of the dual-emissive properties of 
cyclometalated Iridium (III)-polypyridine complexes in the development of luminescent 
biological probes. Angew. Chem. Int. Ed. Engl. 2008, 120, 2245–2248. 
5. Lo, K.K.; Zhang, K.Y.; Chung, C.K.; Kwok, K.Y. Synthesis, photophysical and electrochemical 
properties, and protein-binding studies of luminescent cyclometalated Iridium(III) bipyridine 
estradiol conjugates. Chem. Eur. J. 2007, 13, 7110–7120. 
6. Nelissen, H.F.M.; Kercher, M.; De Cola, L.; Feiters, M.C.; Nolte, R.J.M. Photoinduced electron 
transfer between metal-coordinated cyclodextrin assemblies and viologens. Chem. Eur. J. 2002, 8, 
5407–5414. 
7. Lohse, O.; Thevenin, P.; Waldvogel, E. The palladium catalysed Suzuki coupling of 2- and 4-
chloropyridines. Synlett 1999, 45–48. 
8. Beyer, B.; Ulbricht, C.; Escudero, D.; Friebe, C.; Winter, A.; Gonzalez, L.; Schubert, U.S. 
Phenyl-1H-[1,2,3]triazoles as new cyclometalating ligands for Iridium(III) complexes. 
Organometallics 2009, 28, 5478–5488. 
9. Szejtli, J. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 1998, 98, 
1743–1754. 
10. Wenz, G.; Han, B.H.; Müller, A. Cyclodextrin rotaxanes and polyrotaxanes. Chem. Rev. 2006, 
106, 782–817. 
11. Hapiot, F.; Tilloy, S.; Monflier, E. Cyclodextrins as supramolecular hosts for organometallic 
complexes. Chem. Rev. 2006, 106, 767–781. 
12. Dodziuk, H. Cyclodextrin and Their Complexes: Chemistry, Analytical Methods, Applications; 
Wiley-VCH: Weinheim, Germany, 2006. 
13. Breslow, R.; Dong, S.D. Biomimetic reactions catalyzed by cyclodextrins and their derivatives. 
Chem. Rev. 1998, 98, 1997–2011. 
14. Douhal, A. Cyclodextrin Materials Photochemistry, Photophysics and Photobiology; Elsevier: 
Amsterdam, The Netherlands, 2006. 
15. Haider, J.M.; Williams, R.M.; De Cola, L.; Pikramenou, Z. Vectorial control of energy-transfer 
processes in metallocyclodextrin heterometallic assemblies. Angew. Chem. Int. Ed. Engl. 2003, 
42, 1830–1833. 
16. Haider, J.M.; Pikramenou, Z. Photoactive metallocyclodextrins: Sophisticated supramolecular 
arrays for the construction of light activated miniature devices. Chem. Soc. Rev. 2005, 34,  
120–132. 
17. Faiz, J.A.; Spencer, N.; Pikramenou, Z. Acetylenic cyclodextrins for multireceptor architectures: 
Cups with sticky ends for the formation of extension wires and junctions. Org. Biomol. Chem. 
2005, 3, 4239–4245. 
18. Beck, D.; Brewer, J.; Lee, J.; McGraw, D.; DeGraff, B.A.; Demas, J.N. Localizing molecular 
probes: Inclusion of Re(I) complexes in β-cyclodextrin. Coord. Chem. Rev. 2007, 251, 546–553. 
19. Felici, M.; Contreras-Carballada, P.; Vida, Y.; Smits, J.M.M.; Nolte, R.J.M.; De Cola, L.; 
Williams, R.M.; Feiters, M.C. Ir(III) and Ru(II) Complexes containing triazole-pyridine ligands: 
Molecules 2010, 15                            
 
 
2058
Luminescence enhancement upon substitution with β-cyclodextrin. Chem. Eur. J. 2009, 15, 
13124–13134. 
20. Lim, C.W.; Crespo-Biel, O.; Stuart, M.C.A.; Reinhoudt, D.N.; Huskens, J.; Ravoo, B.J. 
Intravesicular and intervesicular interaction by orthogonal multivalent host-guest and metal-
ligand complexation. Proc. Natl. Acad. Sci. USA 2007, 104, 6986–6991. 
21. Nelissen, H.F.M.; Schut, A.F.J.; Feiters, M.C.; Nolte, R.J.M.; Venema, F. Switch-on 
luminescence detection of steroids by tris(bipyridyl)ruthenium(II) Complexes containing multiple 
cyclodextrin binding sites. Chem. Commun. 2000, 2000, 577–578. 
22. Voskuhl, J.; Ravoo, B.J. Molecular recognition of bilayer vesicles. Chem. Soc. Rev. 2009, 38, 
495–505. 
23. Akare, S.; Martinez, J.D. Bile acid induces hydrophobicity-dependent membrane alterations. 
Biochim. Biophys. Acta 2005, 1735, 59–67. 
24. Kessel, D.; Caruso, J.A.; Reiners, J.J. Potentiation of photodynamic therapy by ursodeoxycholic 
acid. Cancer Res. 2000, 60, 6985–6988. 
25. Heuman, D.M. Bile salt-membrane interactions and the physico-chemical mechanisms of bile salt 
toxicity. Ital. J. Gastroenterol. 1995, 27, 372–375. 
26. Lo, K.K.W. Luminescent transition metal complexes as biological labels and probes. Struct. Bond 
2007, 123, 205–245. 
27. Kolb, H.C.; Finn, M.G.; Sharpless, K.B. Click chemistry: Diverse chemical function from a few 
good reactions. Angew. Chem. Int. Ed. 2001, 40, 2004–2021. 
28. Obata, M.; Kitamura, A.; Mori, A.; Kameyama, C.; Czaplewska, J.A.; Tanaka, R.; Kinoshita, I.; 
Kusumoto, T.; Hashimoto, H.; Harada, M.; Mikata, Y.; Funabiki, T.; Yano, S. Syntheses, 
structural characterization and photophysical properties of 4-(2-pyridyl)-1,2,3-triazole Rhenium(I) 
complexes. Dalton Trans. 2008, 3292–3300. 
29. David, O.; Maisonneuve, S.; Xie, J. Generation of new fluorophore by click chemistry: Synthesis 
and properties of β-cyclodextrin substituted by 2-pyridyl triazole. Tetrahedron Lett. 2007, 48, 
6527–6530. 
30. Ryu, E.H.; Ellern, A.; Zhao, Y. High guest inclusion in 3β-amino-7α, 12α-dihydroxycholan-24-
oic acid enabled by charge-assisted hydrogen bonds. Tetrahedron 2006, 62, 6808–6813. 
31. Hofmann, A.F.; Sjövall, J.; Kurz, G.; Radominska, A.; Schteingart, C.D.; Tint, G.S.; Vlahcevic, 
Z.R.; Setchell, K.D.R. A proposed nomenclature for bile acids. J. Lipid Res. 1992, 33, 599–604. 
32. Nonoyama, M. Benzo[h]quinolin-10-yl-N Iridium(III) complexes. Bull. Chem. Soc. Jpn. 1974, 47, 
767–768. 
33. McGee, K.A.; Mann, K.R. Selective low-temperature syntheses of facial and meridional tris-
cyclometalated Iridium(III) complexes. Inorg. Chem. 2007, 46, 7800–7809. 
34. Kalyanasundaram, K. Photochemistry of Polypyridine and Porphyrin Complexes; Academic 
Press: New York, NY, USA, 1992. 
35. Guerrero-Martínez, A.; Vida, Y.; Domínguez-Gutiérrez, D.; Albuquerque, R.Q.; De Cola, L. 
Tuning emission properties of Iridium and Ruthenium metallosurfactants in micellar systems. 
Inorg. Chem. 2008, 47, 9131–9133. 
Molecules 2010, 15                            
 
 
2059
36. Dominguez-Gutiérrez, D.; De Paoli, G.; Guerrero-Martinez, A.; Ginocchietti, G.; Ebeling, D.; 
Eiser, E.; De Cola, L.; Elsevier, C.J. Inverted aggregates of luminescent Ruthenium 
metallosurfactants. J. Mater. Chem. 2008, 18, 2762–2768. 
37. Mak, C.S.; Hayer, A.; Pascu, S.I.; Watkins, S.E.; Holmes, A.B.; Köhler, A.; Friend, R.H. Blue-to-
green electrophosphorescence of Iridium-based cyclometallated materials. Chem. Commun. 2005, 
4708–4710. 
38. Sheldrick, G.M. SHELXL-97. Program for the Refinement of Crystal Structures; University of 
Göttingen: Göttingen, Germany, 1997. 
39.  de Gelder, R.; de Graaff, R.A.G.; Schenk, H. Automatic determination of crystal structures using 
Karle-Hauptman matrices. Acta Cryst. 1993, A49, 287–293. 
40. WARNING: In the first step of this synthesis methyl-azide was formed but never isolated. In fact 
it is known that organic azides, especially the small ones, can be highly explosive. For organic 
azides, the ‘rule of six’ is very useful: six carbons (or other atoms of about the same size) per 
energetic functional group (azide, diazo, nitro, etc.) provides sufficient dilution to render the 
compound relatively safe. Sodium azide is relatively safe, unless acidified to form HN3, which is 
volatile and highly toxic. For these reasons, azides should not be distilled or treated in a careless 
fashion. We have never experienced a safety problem with these materials. Kolb, H.C.; Finn, 
M.G.; Sharpless, K.B. Angew. Chem. Int. Ed. 2001, 40, 2004–2021. 
 
Sample Availability: Not Available. 
© 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. 
This article is an open-access article distributed under the terms and conditions of the Creative 
Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). 
 
